Cambridge, United Kingdom

Sukhbinder Singh Klair



 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 52(Granted Patents)


Location History:

  • Sawston, GB (2011 - 2013)
  • Hertfordshire, GB (2016)
  • Welwyn Garden City, GB (2017)
  • Cambridge, GB (2013 - 2019)

Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Sukhbinder Singh Klair: Innovator in Neurological Research

Introduction

Sukhbinder Singh Klair is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of neurological and psychiatric disorders through his innovative research and development of novel compounds. With a total of seven patents to his name, Klair's work is recognized for its potential impact on treatment methodologies.

Latest Patents

Among his latest patents are the orexin receptor antagonists. These disclosures relate to novel compounds of a specific formula, wherein W, X, and Y are defined. The compounds are designed for use in treating, preventing, ameliorating, controlling, or reducing the risk of neurological or psychiatric disorders associated with orexin receptors. This innovative approach highlights Klair's commitment to advancing medical science.

Career Highlights

Sukhbinder Singh Klair has worked with notable companies such as Heptares Therapeutics Limited and Cancer Research Technology Limited. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Miles Stuart Congreve and John Andrew Christopher. Their collaborative efforts have further enhanced the research and development of innovative solutions in the medical field.

Conclusion

Sukhbinder Singh Klair's contributions to the field of neurological research through his patents and collaborations underscore his role as a leading inventor. His work continues to pave the way for advancements in the treatment of psychiatric disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…